MeSH term
Frequency | Condition_Probility | Acetylation | 2 | 0.0 |
Base Sequence | 23 | 0.0 |
Brain/metabolism | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
DNA Methylation | 17 | 2.0 |
Female | 52 | 0.0 |
Gene Expression | 14 | 0.0 |
Genomic Imprinting | 10 | 5.0 |
Humans | 79 | 0.0 |
Male | 48 | 0.0 |
Phenotype | 10 | 0.0 |
Research Support, Non-U.S. Gov't | 60 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Blotting, Southern | 6 | 0.0 |
*DNA Methylation | 7 | 1.0 |
*Genomic Imprinting | 24 | 8.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
RNA, Untranslated/genetics | 3 | 10.0 |
Ribonucleoproteins, Small Nuclear/genetics | 6 | 42.0 |
Sulfites/metabolism | 2 | 20.0 |
Animals | 24 | 0.0 |
Autoantigens/*genetics | 29 | 40.0 |
Cell Line | 9 | 0.0 |
CpG Islands | 4 | 1.0 |
DNA | 2 | 0.0 |
Exons | 6 | 0.0 |
Mice | 21 | 0.0 |
Molecular Sequence Data | 24 | 0.0 |
*Ribonucleoproteins, Small Nuclear | 25 | 47.0 |
Alleles | 12 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Mothers | 4 | 4.0 |
*Protein Kinases | 2 | 3.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Time Factors | 4 | 0.0 |
*Transcription Factors | 2 | 0.0 |
DNA, Complementary/*genetics | 2 | 0.0 |
Embryonic Development/*genetics | 2 | 18.0 |
Gene Amplification | 2 | 0.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Genomic Imprinting/*genetics | 8 | 10.0 |
Oocytes/*physiology | 2 | 5.0 |
Pregnancy | 6 | 0.0 |
Chromosome Deletion | 6 | 0.0 |
Chromosomes, Human, Pair 15/genetics | 10 | 14.0 |
In Situ Hybridization, Fluorescence | 23 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Autoantigens/genetics | 6 | 17.0 |
Insulin-Like Growth Factor II/*genetics | 3 | 2.0 |
Middle Aged | 5 | 0.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Pedigree | 9 | 0.0 |
Polymerase Chain Reaction | 14 | 0.0 |
*Alleles | 2 | 0.0 |
Chromosomes, Human, Pair 15 | 6 | 4.0 |
DNA Primers | 7 | 0.0 |
Ribonucleoproteins, Small Nuclear/*genetics | 14 | 82.0 |
Transcription, Genetic | 7 | 0.0 |
Adolescent | 14 | 0.0 |
Adult | 17 | 0.0 |
Child | 16 | 0.0 |
Child, Preschool | 15 | 0.0 |
*Chromosome Aberrations | 4 | 0.0 |
*Chromosomes, Human, Pair 15 | 23 | 10.0 |
Infant | 6 | 0.0 |
Karyotyping | 5 | 0.0 |
Prader-Willi Syndrome/*genetics | 30 | 38.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Chromosome Banding | 7 | 0.0 |
*Chromosome Deletion | 11 | 1.0 |
Abnormalities, Multiple/*genetics | 2 | 0.0 |
Genetic Markers | 7 | 0.0 |
Genotype | 4 | 0.0 |
In Situ Hybridization, Fluorescence/methods | 2 | 2.0 |
Autoantigens/*genetics/metabolism | 2 | 33.0 |
Mice, Knockout | 2 | 0.0 |
Prader-Willi Syndrome/genetics | 7 | 33.0 |
*Sequence Deletion | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Ribonucleoproteins, Small Nuclear/genetics/metabolism | 2 | 66.0 |
*Gene Duplication | 3 | 2.0 |
Amino Acid Sequence | 4 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Mice, Inbred Strains | 3 | 0.0 |
Ubiquitin-Protein Ligases | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Conserved Sequence | 3 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Chromosomes, Human, Pair 15/*genetics | 7 | 7.0 |
Prader-Willi Syndrome/*diagnosis/genetics | 6 | 75.0 |
Angelman Syndrome/genetics | 3 | 23.0 |
Cell Line, Transformed | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Methylation | 10 | 1.0 |
Angelman Syndrome/*genetics | 9 | 18.0 |
Chromosome Aberrations | 2 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
*Exons | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Fathers | 3 | 5.0 |
Microsatellite Repeats | 3 | 0.0 |
Translocation, Genetic | 4 | 0.0 |
Chromosome Mapping | 13 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 3 | 0.0 |
*Translocation, Genetic | 4 | 0.0 |
Angelman Syndrome/*diagnosis/genetics | 3 | 37.0 |
Comparative Study | 6 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
*RNA, Untranslated | 2 | 1.0 |
Abnormalities, Multiple/genetics/pathology | 2 | 12.0 |
Transfection | 3 | 0.0 |
Angelman Syndrome/diagnosis/*genetics | 2 | 40.0 |
Sequence Deletion/genetics | 2 | 1.0 |
DNA/analysis | 5 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Multigene Family/*genetics | 2 | 1.0 |
Proteins/genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
DNA Probes | 3 | 0.0 |
Crosses, Genetic | 3 | 0.0 |
Prader-Willi Syndrome/*diagnosis/*genetics | 3 | 100.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Muridae | 2 | 1.0 |
